CBIO
Crescent Biopharma, Inc.
$17.09
+0.01 (+0.06%)
At close · Jul 2
Market Cap
$471.25M
Shares
27,571,935
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q/A | 2026-06-22 | 2026-03-31 | |
| 8-K | 2026-06-03 | 2026-06-02 | |
| 10-Q | 2026-04-29 | 2026-03-31 | |
| 8-K | 2026-04-29 | — | |
| DEF 14A | 2026-04-21 | 2026-06-02 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2025-12-04 | 2025-12-02 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-07-31 | 2025-07-29 | |
| 8-K | 2025-06-18 | 2025-06-13 | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 8-K | 2025-05-30 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-04-29 | 2025-04-28 | |
| 8-K | 2025-02-25 | 2025-02-19 | |
| 8-K | 2025-02-14 | — | |
| 10-K | 2025-02-13 | 2024-12-31 | |
| 8-K | 2025-01-31 | 2025-01-29 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-26 | 2024-12-19 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-29 | 2024-10-28 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-30 | 2024-07-24 | |
| 8-K | 2024-06-26 | 2024-06-21 | |
| 8-K | 2024-06-13 | 2024-06-10 | |
| 8-K | 2024-06-04 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-06 | — | |
| 8-K | 2024-05-02 | 2024-05-01 | |
| DEF 14A | 2024-04-01 | 2024-05-01 | |
| 8-K | 2024-03-27 | — | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2024-03-01 | — | |
| 8-K | 2024-01-02 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-03 | — | |
| 8-K | 2023-08-02 | — | |
| 10-Q | 2023-08-02 | 2023-06-30 | |
| 8-K | 2023-05-22 | 2023-05-19 | |
| 10-Q | 2023-05-03 | 2023-03-31 | |
| 8-K | 2023-05-03 | — | |
| DEF 14A | 2023-04-21 | 2023-05-19 | |
| 8-K | 2023-04-21 | 2023-04-19 | |
| 10-K | 2023-03-29 | 2022-12-31 | |
| 8-K | 2023-03-29 | — |
Showing 1–50 of 90 filings